Circulating thyroid antibodies in congenital hypothyroidism

Area of Science:

• Endocrinology
• Immunology
• Neonatology

Background:

• Congenital hypothyroidism (CH) is a condition present at birth affecting thyroid function.
• The role of maternal thyroid antibodies in the development of CH remains controversial.
• Understanding maternal factors is crucial for diagnosing and managing neonatal thyroid disorders.

Purpose of the Study:

• To investigate the prevalence and impact of maternal thyroid antibodies in congenital hypothyroidism.
• To determine if maternal thyroid antibodies contribute to the aetiology of CH.
• To analyze specific antibodies like TSH receptor (TSH-R), thyroid peroxidase (TPO), and thyroglobulin (Tg) antibodies.

Main Methods:

• Utilized a bioassay with rat thyroid cell line (FRTL5) to measure TSH-stimulated cAMP production.
• Quantified serum antibodies against TSH-R, TPO, and Tg using radioreceptor assays and ELISA.
• Analyzed IgG from 89 mothers and sera from 144 newborn patients.

Main Results:

• No increased prevalence of thyroid antibodies was observed in mothers compared to controls.
• One case of transient neonatal hyperthyrotropinemia was linked to maternal TSH receptor blocking antibodies.
• Maternal immunoglobulin transfer showed a limited role in congenital thyroid dysfunction aetiology.

Conclusions:

• Maternal thyroid antibodies have a limited role in the aetiology of congenital hypothyroidism.
• Transplacental transfer of TSH receptor antibodies is a notable exception.
• Further research may clarify specific antibody mechanisms in neonatal thyroid health.